Search Result "Human malignant pleural mesothelioma cells"
Improvement of malignant pleural mesothelioma immunotherapy by epigenetic modulators
Journal: Current Topics in Medicinal Chemistry
Volume: 16 Issue: 7 Year: 2016 Page: 777-787
Author(s): Malik Hamaidia,Bernard Staumont,Bernard Duysinx,Renaud Louis,Luc Willems
Molecular Targets in Malignant Pleural Mesothelioma Treatment
Journal: Current Drug Targets
Volume: 10 Issue: 1 Year: 2009 Page: 1235-1244
Author(s): Giulia Pasello, Adolfo Favaretto
Malignant Pleural Mesothelioma (MPM): Latent Disease
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 7 Year: 2016
Author(s): M. Genovés Crespo,F.J. Callejas González,R.D. GarcÃa Ãngel,W. Mayoris Almonte,F.J. AgustÃn MartÃnez
Doi: 10.2174/9781681082516116070003
The Role of microRNAs in the Diagnosis and Treatment of Malignant Pleural Mesothelioma - A Short Review
Journal: MicroRNA
Volume: 1 Issue: 1 Year: 2012 Page: 40-48
Author(s): Kelly W. Sheff,Mir A. Hoda,Balazs Dome,Balazs Hegedus,Walter Klepetko,Glen J. Weiss
Virus Oncogenesis of Malignant Pleural Mesothelioma
Ebook: Malignant Pleural Mesothelioma: Present Status and Future Directions
Volume: 1 Year: 2016
Author(s): Giovanni Gaudino,Fang Qi,Haining Yang,Michele Carbone
Doi: 10.2174/9781681081946116010015
Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma
Journal: MicroRNA
Volume: 5 Issue: 1 Year: 2016 Page: 12-18
Author(s): Anna Truini, Simona Coco, Carlo Genova, Marco Mora, Maria G. Dal Bello, Irene Vanni, Angela Alama, Erika Rijavec, Giulia Barletta, Federica Biello, Claudia Maggioni, Francesco Grossi
Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 2 Year: 2010 Page: 176-191
Author(s): R. E. Favoni, A. Pattarozzi, M. Lo Casto, F. Barbieri, M. Gatti, L. Paleari, A. Bajetto, C. Porcile, G. Gaudino, L. Mutti, G. Corte, T. Florio, M. Casto
Malignant Mesothelioma
Ebook: Modern Occupational Diseases Diagnosis, Epidemiology, Management and Prevention
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815049138122010013
Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target
Journal: Current Cancer Therapy Reviews
Volume: 13 Issue: 2 Year: 2017 Page: 76-88
Author(s): Bently P. Doonan,Kei Ohnuma,Long H. Dang,Chikao Morimoto,Nam H. Dang
Biological Agents Involved in Malignant Mesothelioma: Relevance as Biomarkers or Therapeutic Targets
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 1 Year: 2010 Page: 19-26
Author(s): S. Crispi, I. Cardillo, E. P. Spugnini, G. Citro, S. Menegozzo, A. Baldi